Plasminogen activator
From Proteopedia
(Difference between revisions)
| Line 19: | Line 19: | ||
[[1tpk]] - hTPA kringle 2 domain<br /> | [[1tpk]] - hTPA kringle 2 domain<br /> | ||
[[1tpm]], [[1tpn]] - hTPA fibrin-binding domain – NMR | [[1tpm]], [[1tpn]] - hTPA fibrin-binding domain – NMR | ||
| + | |||
| + | ==Urokinase-type plasminogen activator [[Urokinase]]== | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 07:18, 13 December 2011
Plasminogen activator (PLA) is a serine protease which converts plasminogen to plasmin. It includes Tissue PLA (TPA) which is involved in breakdown of blood clots and urokinase-type PLA Urokinase. TPA structure contains heavy and light chains (HC, LC). PLA is inhibited by PLA inhibitor 1 and 2.
Contents |
3D structures of plasminogen activator
1a5i – PLA residues 213-477 + EGR-CMK – Vampire bat
1bqy – PLA – Pit viper
Tissue plasminogen activator
1a5h – hTPA HC+LC + benzamidine – human
1rtf - hTPA HC+LC
1tpg – hTPA F1-G - NMR
1bda – hTPA catalytic domain (mutant) + EGR-CMK
1pk2 – hTPA kringle 2 domain + 6-aminohexanoic acid – NMR
1tpk - hTPA kringle 2 domain
1tpm, 1tpn - hTPA fibrin-binding domain – NMR
